The end of cancer treatment is reason to celebrate and a relief for patients and their families, but it can also be a time of new concerns. Vanderbilt-Ingram Cancer Center offers the REACH for Survivorship Program, a comprehensive clinic for survivors of all ages who have faced any type of cancer and who have received […]
Other than skin cancer, prostate cancer is the most common cancer in American men, with about one in nine being diagnosed during his lifetime. Available treatments are effective for many men, but scientists are just beginning to discover the best way to tailor care to the specific characteristics of each individual patient’s cancer. “We physicians […]
Fortitude is threaded through the stories in this Momentum. Fortitude is what gives people battling cancer the strength to scale their obstacles. It is what cancer survivors use to lift up new patients. And it is what our researchers grip as they pursue research projects that can span years. Thomas Brewer has fortitude. Having beat […]
In early 2014, Mary Beth Ballard and her husband, Chris Murray, were searching for their first home together in Middle Tennessee when she noticed something she initially dismissed as a sign of a minor infection—a small amount of blood in her urine. Between house hunting and a new job, her schedule was hectic. The blood […]
For many patients of the Vanderbilt Breast Center, their first direct contact with the clinic is a pre-appointment telephone call from Norma Campbell, R.N., one of the center’s two nurse coordinators. “Sometimes these patients are just really, really afraid, or they just want to put a face to a name, and during this call they’ll […]
A Vanderbilt-Ingram Cancer Center (VICC) researcher is leading the nation’s largest-ever study of breast cancer genetics in African-American women—a $12 million initiative funded by the National Cancer Institute to determine the factors that make breast cancer deadlier for black women. Our cover story about the Breast Cancer Genetic Study in African-Ancestry Populations, for which Dr. […]
New target for colorectal cancer In a study published March 6 in the journal Oncogene, Dana Hardbower, Ph.D., Keith Wilson, M.D., and colleagues demonstrated that epidermal growth factor receptor (EGFR) signaling in macrophages is associated with increased colitis-associated colon cancer development. While inflammatory bowel disease and colitis can increase the risk of colon cancer, the […]
VICC committed to increasing HPV vaccinations Vanderbilt-Ingram Cancer Center (VICC) experts and the Prevent Cancer Foundation urged the public to “think about the link” between viruses and cancer during a July seminar. The event, held in conjunction with the Tennessee Cancer Consortium’s annual conference, was one of several initiatives by VICC during 2017 to raise […]
I have been through a storm. And I don’t just mean any storm. I mean a tsunami. A tsunami generally consists of a series of waves with periods ranging from minutes to hours occurring in a so-called wave train. That’s what having ovarian cancer felt like to me. It was waves of different emotions, waves […]
Tuya Pal, M.D., has spent much of her life trying to unravel scientific mysteries. As a little girl she was already learning, competing and moving fast. The child of first-generation immigrants who moved from India to Canada where her father earned a scholarship to study engineering, Pal was a competitive swimmer who also loved to […]
